Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source
- PMID: 16052568
- DOI: 10.1002/art.21212
Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source
Abstract
Objective: To compare the properties of human mesenchymal stem cells (MSCs) isolated from bone marrow, synovium, periosteum, skeletal muscle, and adipose tissue.
Methods: Human mesenchymal tissues were obtained from 8 donors during knee surgery for ligament injury. After collagenase digestion or gradient-density separation, nucleated cells were plated at an appropriate density for expansion at the maximum rate without colony-to-colony contact. Yield, expandability, differentiation potential, and epitope profile were compared among MSCs from the 5 different tissue sources.
Results: Colony number per 10(3) nucleated cells was lower, and cell number per colony was higher, in bone marrow than in other mesenchymal tissues. When the cells were replated at low density every 14 days, bone marrow-, synovium-, and periosteum-derived cells retained their proliferation ability even at passage 10. In chondrogenesis studies in which the cells were pelleted and cultured in vitro, pellets from bone marrow-, synovium-, and periosteum-derived cells were shown to be larger and stained more extensively for cartilage matrix. Synovium-derived cells, in particular, had the greatest ability for chondrogenesis. In adipogenesis experiments, the frequency of oil red O-positive colonies was highest in synovium- and adipose tissue-derived cells. In studies of osteogenesis, the rate of alizarin red-positive colonies was highest in bone marrow-, synovium-, and periosteum-derived cells. For epitope profiling, 15 surface antigens were measured. Most appeared to have similar epitope profiles irrespective of cell source.
Conclusion: Our findings indicate that there are significant differences in MSC properties according to tissue source, beyond donor and experimental variation. Superiority of synovium as a potential source of MSCs for clinical applications was demonstrated.
Similar articles
-
Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle.Cell Tissue Res. 2007 Mar;327(3):449-62. doi: 10.1007/s00441-006-0308-z. Epub 2006 Oct 13. Cell Tissue Res. 2007. PMID: 17053900
-
In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells.J Cell Biochem. 2006 Jan 1;97(1):84-97. doi: 10.1002/jcb.20546. J Cell Biochem. 2006. PMID: 16088956
-
Higher chondrogenic potential of fibrous synovium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells: distinguishing properties of mesenchymal stem cells in humans.Arthritis Rheum. 2006 Mar;54(3):843-53. doi: 10.1002/art.21651. Arthritis Rheum. 2006. PMID: 16508965
-
Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration.Tissue Eng Part B Rev. 2009 Mar;15(1):75-86. doi: 10.1089/ten.teb.2008.0586. Tissue Eng Part B Rev. 2009. PMID: 19196118 Review.
-
Mesenchymal stem cells: clinical applications and biological characterization.Int J Biochem Cell Biol. 2004 Apr;36(4):568-84. doi: 10.1016/j.biocel.2003.11.001. Int J Biochem Cell Biol. 2004. PMID: 15010324 Review.
Cited by
-
Clinical perspectives for repairing rotator cuff injuries with multi-tissue regenerative approaches.J Orthop Translat. 2022 Aug 24;36:91-108. doi: 10.1016/j.jot.2022.06.004. eCollection 2022 Sep. J Orthop Translat. 2022. PMID: 36090820 Free PMC article. Review.
-
Stem cell therapy for voiding and erectile dysfunction.Nat Rev Urol. 2012 Aug;9(8):435-47. doi: 10.1038/nrurol.2012.111. Epub 2012 Jun 19. Nat Rev Urol. 2012. PMID: 22710667 Free PMC article. Review.
-
Cardiac cell therapy: boosting mesenchymal stem cells effects.Stem Cell Rev Rep. 2013 Jun;9(3):266-80. doi: 10.1007/s12015-012-9353-z. Stem Cell Rev Rep. 2013. PMID: 22350458 Review.
-
Impact of aging on the regenerative properties of bone marrow-, muscle-, and adipose-derived mesenchymal stem/stromal cells.PLoS One. 2014 Dec 26;9(12):e115963. doi: 10.1371/journal.pone.0115963. eCollection 2014. PLoS One. 2014. PMID: 25541697 Free PMC article.
-
Chondrogenic differentiation of amniotic fluid stem cells and their potential for regenerative therapy.Stem Cell Rev Rep. 2012 Dec;8(4):1267-74. doi: 10.1007/s12015-012-9405-4. Stem Cell Rev Rep. 2012. PMID: 22869300 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources